Prices are updated after-hours


Sort by: gain open | gain high | gain close | publishing date

symbols : AGNPF    save search

Algernon Pharmaceuticals Files for Clinical Trial and Ethics Approval for Phase 1 DMT Human Stroke Study
Published: 2022-01-19 (Crawled : 12:30) - globenewswire.com
AGNPF | $6.6157 | twitter stocktwits trandingview |
Health Technology
| | O: 1.33% H: 1.73% C: -14.06%

als trial approval stroke phase 1
Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 2b Ifenprodil Chronic Cough Study
Published: 2022-01-14 (Crawled : 15:00) - biospace.com/
AGNPF | $6.6157 | twitter stocktwits trandingview |
Health Technology
| | O: 9.2% H: 0.0% C: -4.78%

fda phase 2 als ces phase 2b positive chronic cough
Streetwise Reports – Algernon Pharmaceuticals Looks to U.S. for Help Fighting Strokes
Published: 2022-01-05 (Crawled : 03:00) - algernonpharmaceuticals.com
AGNPF | $6.6157 | twitter stocktwits trandingview |
Health Technology
| | O: -2.17% H: 9.52% C: 9.52%

als stroke
Algernon Pharmaceuticals Issues Compensation Options
Published: 2022-01-04 (Crawled : 19:00) - globenewswire.com
AGNPF | $6.6157 | twitter stocktwits trandingview |
Health Technology
| | O: 0.81% H: 0.0% C: -0.03%

als
Algernon Pharmaceuticals Completes Manufacturing of Psychedelic Drug DMT Appoints UK Stroke Experts for Phase 2
Published: 2021-12-08 (Crawled : 12:30) - globenewswire.com
AGNPF | $6.6157 | twitter stocktwits trandingview |
Health Technology

phase 2 drug stroke
Algernon Pharmaceuticals Projects Full Enrollment for Phase 2 IPF and Chronic Cough Trial
Published: 2021-12-02 (Crawled : 16:00) - biospace.com/
AGNPF | $6.6157 | twitter stocktwits trandingview |
Health Technology

phase 2 trial chronic cough
Algernon Pharmaceuticals Announces New Chief Financial Officer
Published: 2021-11-30 (Crawled : 12:00) - globenewswire.com
AGNPF | $6.6157 | twitter stocktwits trandingview |
Health Technology

MCUJF | $0.83 | twitter stocktwits trandingview |
Health Technology


Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 1 Ifenprodil Small Cell Lung Cancer Study
Published: 2021-11-24 (Crawled : 12:00) - globenewswire.com
AGNPF | $6.6157 | twitter stocktwits trandingview |
Health Technology
| | O: 14515.38% H: 0.0% C: -1.95%

fda lung cancer phase 1 positive cancer
Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human Stroke Study
Published: 2021-11-19 (Crawled : 12:00) - globenewswire.com
AGNPF | $6.6157 | twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: -2.5%

stroke phase 1 positive
Algernon Pharmaceuticals Announces Share Consolidation
Published: 2021-11-17 (Crawled : 23:00) - globenewswire.com
AGNPF | $6.6157 | twitter stocktwits trandingview |
Health Technology
| | O: -4.23% H: 3.41% C: -19.68%


Algernon Pharmaceuticals Establishes 6 hours as Optimum Treatment Period for DMT in Neuron Study
Published: 2021-11-01 (Crawled : 19:00) - biospace.com/
AGNPF | $6.6157 | twitter stocktwits trandingview |
Health Technology
| | O: -4.6% H: 5.49% C: 4.83%

treatment
Algernon Pharmaceuticals Announces Receipt of CAD$2M Cash Refund from Australian Research Program and Files Application to List its Common Shares on Nasdaq Capital Market
Published: 2021-10-21 (Crawled : 13:00) - biospace.com/
AGNPF | $6.6157 | twitter stocktwits trandingview |
Health Technology
| | O: -1.64% H: 11.67% C: 8.0%

application australia research
Algernon Files Meeting Request with MHRA for Use of DMT in Phase 1/2a Human Stroke Study
Published: 2021-10-13 (Crawled : 12:00) - biospace.com/
AGNPF | $6.6157 | twitter stocktwits trandingview |
Health Technology
| | O: -0.31% H: 0.0% C: -0.77%

stroke phase 1
Algernon Pharmaceuticals Files U.S. FDA Pre-IND Meeting Request for Ifenprodil Chronic Cough Phase 2 Study
Published: 2021-10-08 (Crawled : 12:00) - biospace.com/
AGNPF | $6.6157 | twitter stocktwits trandingview |
Health Technology
| | O: -7.45% H: 16.61% C: 11.3%

fda phase 2 chronic cough
Algernon Pharmaceuticals Announces the Appointment of Dr. Mark Williams to the Board of Directors
Published: 2021-09-22 (Crawled : 12:15) - biospace.com/
AGNPF | $6.6157 | twitter stocktwits trandingview |
Health Technology


Algernon Pharmaceuticals Files U.S. FDA Pre-IND Meeting Request for Ifenprodil Small Cell Lung Cancer Study
Published: 2021-09-22 (Crawled : 12:00) - globenewswire.com
AGNPF | $6.6157 | twitter stocktwits trandingview |
Health Technology

fda lung cancer cancer
Algernon Pharmaceuticals Announces Plans for a Phase 2 Ifenprodil Chronic Cough Study in the U.S.
Published: 2021-09-20 (Crawled : 12:00) - biospace.com/
AGNPF | $6.6157 | twitter stocktwits trandingview |
Health Technology

phase 2 chronic cough
Algernon Pharmaceuticals Announces Appointment of Harry Bloomfield, QC. as a New Board Director and Chairman
Published: 2021-09-09 (Crawled : 19:00) - biospace.com/
GNOLF | $0.015 | twitter stocktwits trandingview |
Energy Minerals

AGNPF | $6.6157 | twitter stocktwits trandingview |
Health Technology


Algernon Pharmaceuticals CEO To Deliver Virtual Keynote Presentation on Company’s DMT Program at the International Microdose DMT Conference
Published: 2021-09-09 (Crawled : 16:00) - globenewswire.com
AGNPF | $6.6157 | twitter stocktwits trandingview |
Health Technology

presentation ceo liver conference
Algernon Pharmaceuticals Confirms DMT Increased Growth of Neurons by 40% in Preclinical Study at Sub Hallucinogenic Dose
Published: 2021-09-07 (Crawled : 12:00) - globenewswire.com
AGNPF | $6.6157 | twitter stocktwits trandingview |
Health Technology

growth preclinical
Your saved searches


Save your searches and get alerts when important news are released.

Mentioned Today
COTY | News | $8.79 | twitter stocktwits trandingview |
Consumer Non-Durables

DXR | News | $11.075 | twitter stocktwits trandingview |
Health Technology

FCFS | News | $70.6 | twitter stocktwits trandingview |
Finance

INCY | News | $74.95 | twitter stocktwits trandingview |
Health Technology

KRP | News | $14.56 | twitter stocktwits trandingview |
Miscellaneous

LLY | News | $247.43 | twitter stocktwits trandingview |
Health Technology

OVLY | News | $17.5101 | twitter stocktwits trandingview |
Finance